Piramal Pharma, ahead of its demerger with Piramal Enterprises, has inducted three people into its board for assisting the company in "maintaining high governance".
Former Pfizer executive Peter Stevenson, ex-Teva executive Nathalie Leitch and corporate lawyer Sridhar Gorthi are the new board members. The de-merger is expected to be completed by this December.
“These new appointments, which come ahead of the planned demerger of PPL from Piramal Enterprises Ltd (PEL), will assist us in maintaining high governance for the new listed corporate entity,” the company said in a statement. Piramal Pharma draws only 15 percent of its revenues